LMNB2 promotes prostate cancer progression and epithelial-mesenchymal transition via the Wnt/β-catenin pathway

Zhiyu Liu, Yuqi Li, Juan Wang, Yang Zeng, Qilong Wu, Xinyao Zhu, Tao Zhou, Qingfu Deng

Open source

DOI
10.1007/s12672-026-05015-y
Published
2026-04-21
Container
Discover Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12672-026-05015-y,
  title = {LMNB2 promotes prostate cancer progression and epithelial-mesenchymal transition via the Wnt/β-catenin pathway},
  author = {Zhiyu Liu and Yuqi Li and Juan Wang and Yang Zeng and Qilong Wu and Xinyao Zhu and Tao Zhou and Qingfu Deng},
  year = {2026},
  journal = {Discover Oncology},
  doi = {10.1007/s12672-026-05015-y},
  url = {https://doi.org/10.1007/s12672-026-05015-y}
}

RIS

TY  - JOUR
TI  - LMNB2 promotes prostate cancer progression and epithelial-mesenchymal transition via the Wnt/β-catenin pathway
AU  - Zhiyu Liu
AU  - Yuqi Li
AU  - Juan Wang
AU  - Yang Zeng
AU  - Qilong Wu
AU  - Xinyao Zhu
AU  - Tao Zhou
AU  - Qingfu Deng
PY  - 2026
JO  - Discover Oncology
DO  - 10.1007/s12672-026-05015-y
UR  - https://doi.org/10.1007/s12672-026-05015-y
ER  - 

APA

Liu, Z., Li, Y., Wang, J., Zeng, Y., Wu, Q., Zhu, X., Zhou, T., & Deng, Q. (2026). LMNB2 promotes prostate cancer progression and epithelial-mesenchymal transition via the Wnt/β-catenin pathway. Discover Oncology. https://doi.org/10.1007/s12672-026-05015-y

Source records